Bharat Biotech's Covaxin recommended by expert panel for phase 2/3 trials on children

Bharat Biotech’s Covaxin shot has been recommended by the expert panel on Covid-19 for further trials on children aged between 2 and 18 years, said sources.

Bharat Biotech’s Covaxin shot has been recommended by the expert panel on Covid-19 for further trials on children aged between 2 and 18 years, said sources. The Subject Expert Committee (SEC) on Covid-19 has recommended that Bharat Biotech be granted permission to conduct the phase 2/3 clinical trials of Covaxin, on children in the 2-18 age group.